World Bulletin / News Desk
On any given day, some 80,000 patients in Europe are fighting an infection they picked up in hospital, often while in intensive care, the EU's disease monitoring agency said in a survey published on Thursday.
Although some of these infections can be treated easily, others - like the superbug MRSA and other drug-resistant bugs - can be fatal or affect patients' health very seriously, taking several months of costly hospital care and medication to beat.
A survey by the European Centre for Diseases Prevention and Control (ECDC) found that on any given day, one in 18 patients in European hospitals has at least one hospital-acquired infection - amounting to around 3.2 million patients per year.
"Healthcare-associated infections pose a major public health problem and a threat to European patients," said Marc Sprenger, director of the Stockholm-based ECDC.
He said many of these infections could be prevented by well thought-out, sustained and multi-pronged prevention and control programmes and he urged hospitals to step up the fight.
"Such programmes, as well as prudent use of antibiotics, will help all actors involved to protect the patients of European hospitals," he said in a statement.
The ECDC warned last year that doctors are increasingly having to turn to last-ditch antibiotics due to growing drug-resistant superbug infections in Europe - many of them acquired in hospitals.
The latest survey, which covered 1,000 hospitals in 30 European countries, found the highest rates of hospital-acquired infections were among patients admitted to intensive care units, where 19.5 percent of patients had at least one bug they had picked up from the hospital.
The most common types of infection are respiratory tract infections such as pneumonia and infections of the bloodstream. These are often caused by Klebsiella pneumoniae and E. coli bacteria, both of which have shown an ability to develop resistance to some of the most powerful antibiotics.
Among a total 15,000 reported healthcare-associated infections, surgical site infections and urinary tract infections are also common. Many of the infections are also found to be drug-resistant "superbugs", the survey showed.
Among all infections with Staphylococcus aureus bacteria in which full testing was carried out, more than 40 percent were reported as resistant to methicillin - in other words they were MRSA infections, the ECDC said.
Worldwide, MRSA infects an estimated 53 million people annually and costs more than $20 billion a year to treat. It kills around 20,000 people a year in the United States and a similar number in Europe.
EU health and consumer affairs commissioner Paola Testori Coggi said the findings of the European survey were "worrying" and urged health authorities to do more to protect patients in hospital and to step up the fight against antibiotic resistance.
Drug resistance is driven by the misuse and overuse of antibiotics, which encourages bacteria to develop new ways of overcoming them.
Experts say hospitals are often guilty of overusing antibiotics, giving them as "blanket" treatments before full testing has established which drugs are really needed.
The World Health Organization has announced that the Ebola virus has killed some 1,552 people in West Africa, mostly in Liberia, Guinea and Sierra Leone, since the outbreak began in January.
UN deputy secretary general Jan Eliasson said the failure to address the issue of sanitation would prove “disastrous.”
The Ebola outbreak in West Africa has taken 1,552 lives out of 3,069 known cases in four countries and "continues to accelerate", WHO said
Presidential Press Secretary Jerolinmek Piah told AA the names would be announced later.
The WHO urged a range of "regulatory options", including prohibiting e-cigarette makers from making health claims
The doctor died after receiving the experimental drug ZMapp.
Japan has received inquiries from some countries on the influenza drug favipiravir, or T-705 as it is known in the developmental code.
Some 54 people have died in or near the capital Accra, and around 300 people are now being infected daily with the highly contagious disease, putting pressure on local health facilities, said Linda Van-Otoo, GHS director for Greater Accra.
A Philippine seaman is being monitored in Togo for signs of the disease but authorities say the country is still Ebola-free, despite dozens of workers returning from Liberia.
A 36-year-old man from Senegal is being tested in Barcelona.
MSF (Doctors Without Borders) has deployed 1,000 of its own staff in the stricken region, running centres that currently have 300 beds
On Wednesday, the residents of the two communities woke up just after the president ordered the quarantine only to find their community barricaded with soldiers and police officers preventing people from leaving or entering the two areas.
They were given ZMapp, a drug used on a handful of patients in the West African outbreak and produced by U.S.-based Mapp Biopharmaceutical.
A local priest who asked not to be named said that the illness had affected several villages and estimated that the death toll was over 100 people.
The calculation highlights the dilemma facing officials considering how to distribute the tiny quantities of unproven drugs that are likely to be available in the near term
"We are hopeful and grateful to God and to the medical team that they are showing signs of improvement," Liberia's Information Minister Lewis Brown told a press conference on Tuesday.